{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:56:10Z","timestamp":1791197770551,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ureteral stenting in patients with bladder cancer involving the ureteral orifice may increase the rate of metachronous upper tract urothelial carcinoma (UTUC). Nevertheless, evidence on the matter is scarce and often contradictory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We performed an observational study comparing ureteral stenting versus no stenting with respect to the risk of developing metachronous UTUC in patients who underwent transurethral resection of bladder tumors (TURBT) involving the ureteral orifice between January 2015 and December 2024. We performed time-to-event analyses to estimate hazard ratios (HRs) along with their corresponding 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 151 patients with a median age of 73 years. 37 (25%) underwent ureteral stenting during TURBT. Patients undergoing stenting had higher BMI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014), more aggressive tumors (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), underwent prior intravesical therapy more often (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008), higher preoperative creatinine values (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007), and longer hospitalization duration (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) compared to those who did not undergo stenting. After a median follow-up of 25 months, 8 patients developed metachronous UTUC (2 in the stenting group and 6 in the non-stenting group). Ureteral stenting was not associated with statistically significantly higher rates of metachronous UTUC (HR: 1.2, 95%CI: 0.31\u20135.6,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.9). During follow-up, 49 (33%) patients developed recurrence in the bladder, 43 (28%) underwent cystectomy, and 24 (16%) died. The HRs did not significantly differ between the two groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present study did not demonstrate an increased risk of metachronous UTUC after stenting during TURBT with urothelial cancer involving the ureteral orifice. Moreover, stenting was not statistically significantly associated with increased recurrences in the urinary bladder, higher cystectomy rates, or worse mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-026-06839-7","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:53:14Z","timestamp":1791193994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of ureteral stenting on the risk of metachronous upper tract urothelial carcinoma in patients with bladder tumors involving the ureteral orifice"],"prefix":"10.1007","volume":"44","author":[{"given":"Nikolaos","family":"Pyrgidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Engelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Puhr-Westerheide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Kidess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Semmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald Bastian","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-9398","authenticated-orcid":false,"given":"Yannic","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"6839_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","volume":"35","author":"F Soria","year":"2017","unstructured":"Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W et al (2017) Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol 35:379\u2013387. https:\/\/doi.org\/10.1007\/s00345-016-1928-x","journal-title":"World J Urol"},{"key":"6839_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.eururo.2016.09.035","volume":"71","author":"G Gakis","year":"2017","unstructured":"Gakis G, Black PC, Bochner BH, Boorjian SA, Stenzl A, Thalmann GN et al (2017) Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy. Eur Urol 71:545\u2013557. https:\/\/doi.org\/10.1016\/j.eururo.2016.09.035","journal-title":"Eur Urol"},{"key":"6839_CR3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.juro.2016.11.094","volume":"197","author":"N Singla","year":"2017","unstructured":"Singla N, Fang D, Su X, Bao Z, Cao Z, Jafri SM et al (2017) A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States. J Urol 197:1208\u20131213. https:\/\/doi.org\/10.1016\/j.juro.2016.11.094","journal-title":"J Urol"},{"key":"6839_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.juro.2016.01.038","volume":"196","author":"O Rodriguez Faba","year":"2016","unstructured":"Rodriguez Faba O, Gaya JM, Breda A, Juarez Del Dago P, Pisano F, Salas D et al (2016) Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence. J Urol 196:52\u201356. https:\/\/doi.org\/10.1016\/j.juro.2016.01.038","journal-title":"J Urol"},{"key":"6839_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000474814","volume":"21","author":"J Palou","year":"1992","unstructured":"Palou J, Fari\u00f1a LA, Villavicencio H, Vicente J (1992) Upper tract urothelial tumor after transurethral resection for bladder tumor. Eur Urol 21:110\u2013114. https:\/\/doi.org\/10.1159\/000474814","journal-title":"Eur Urol"},{"key":"6839_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.21037\/tau.2017.11.26","volume":"6","author":"R Gupta","year":"2017","unstructured":"Gupta R, Gupta S, Basu S (2017) Double J stent prior to cystectomy increases the risk of upper urinary tract recurrence? Transl Androl Urol 6:1203\u20131204. https:\/\/doi.org\/10.21037\/tau.2017.11.26","journal-title":"Transl Androl Urol"},{"key":"6839_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.juro.2012.08.006","volume":"188","author":"R Mano","year":"2012","unstructured":"Mano R, Shoshany O, Baniel J, Yossepowitch O (2012) Resection of ureteral orifice during transurethral resection of bladder tumor: functional and oncologic implications. J Urol 188:2129\u20132133. https:\/\/doi.org\/10.1016\/j.juro.2012.08.006","journal-title":"J Urol"},{"key":"6839_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.23736\/S0393-2249.19.03311-3","volume":"71","author":"FA Mistretta","year":"2019","unstructured":"Mistretta FA, Carrion DM, Nazzani S, V\u00e1squez JL, Fiori C, De Cobelli O et al (2019) Bladder recurrence of primary upper tract urinary carcinoma following nephroureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer. Minerva Urol E Nefrol Ital J Urol Nephrol 71:191\u2013200. https:\/\/doi.org\/10.23736\/S0393-2249.19.03311-3","journal-title":"Minerva Urol E Nefrol Ital J Urol Nephrol"},{"key":"6839_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.eururo.2018.04.008","volume":"74","author":"G Giannarini","year":"2018","unstructured":"Giannarini G, Crestani A, Ficarra V, Re (2018) Stenting Prior to Cystectomy Is an Independent Risk Factor for Upper Urinary Tract Recurrence. Eur Urol 74:395\u2013396. https:\/\/doi.org\/10.1016\/j.eururo.2018.04.008","journal-title":"Eur Urol"},{"key":"6839_CR10","doi-asserted-by":"publisher","unstructured":"Sood A, Abdollah F, Cole D, Alanee S, Re MA, Furrer PY, Wuethrich FC, Burkhard GN, Thalmann (2017) and B. Roth J Urol ; 198: 1263\u20131268. J Urol 2018;199:1069\u201370. https:\/\/doi.org\/10.1016\/j.juro.2017.11.119","DOI":"10.1016\/j.juro.2017.11.119"},{"key":"6839_CR11","doi-asserted-by":"publisher","unstructured":"Zargar-Shoshtari K, Sexton WJ, Re MA, Furrer PY, Wuethrich FC, Burkhard GN, Thalmann, Roth B (2017) J Urol ; 198: 1263\u20131268. J Urol 2018;200:457\u20138. https:\/\/doi.org\/10.1016\/j.juro.2018.02.3095","DOI":"10.1016\/j.juro.2018.02.3095"},{"key":"6839_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001548.01","author":"F Greco","year":"2021","unstructured":"Greco F, Editorial Comment (2021) J Urol. https:\/\/doi.org\/10.1097\/JU.0000000000001548.01","journal-title":"J Urol"},{"key":"6839_CR13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/JU.0000000000001548","volume":"205","author":"P Sountoulides","year":"2021","unstructured":"Sountoulides P, Pyrgidis N, Brookman-May S, Mykoniatis I, Karasavvidis T, Hatzichristou D (2021) Does Ureteral Stenting Increase the Risk of Metachronous Upper Tract Urothelial Carcinoma in Patients with Bladder Tumors? A Systematic Review and Meta-analysis. J Urol 205:956\u2013966. https:\/\/doi.org\/10.1097\/JU.0000000000001548","journal-title":"J Urol"},{"key":"6839_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupr\u00eat","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ, Capoun O, Comp\u00e9rat EM, Dominguez-Escrig JL et al (2023) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update. Eur Urol 84:49\u201364. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.013","journal-title":"Eur Urol"},{"key":"6839_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet Lond Engl 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet Lond Engl"},{"key":"6839_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21276\/ijmrp.2017.3.2.003","volume":"15","author":"N Kumar Jain","year":"2017","unstructured":"Kumar Jain N, kumar Sokhal A, Jhanwar A, Lashkary N, Hada S, Resident S et al (2017) Does Retrograde Double-J Stenting in Bladder Urothelial Malignancy Predisposes for Tumour Seeding at Upper Urinary Tract: A Study From a Tertiary Care Hospital. Orig Res Artic 15:15\u201317. https:\/\/doi.org\/10.21276\/ijmrp.2017.3.2.003","journal-title":"Orig Res Artic"},{"key":"6839_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0022-5347(17)42984-3","volume":"138","author":"JA De Torres Mateos","year":"1987","unstructured":"De Torres Mateos JA, Banus Gassol JM, Palou Redorta J, Morote Robles J (1987) Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma. J Urol 138:49\u201351. https:\/\/doi.org\/10.1016\/S0022-5347(17)42984-3","journal-title":"J Urol"},{"key":"6839_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0022-5347(17)49028-8","volume":"133","author":"AD Amar","year":"1985","unstructured":"Amar AD, Das S (1985) Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux. J Urol 133:468\u2013471. https:\/\/doi.org\/10.1016\/S0022-5347(17)49028-8","journal-title":"J Urol"},{"key":"6839_CR19","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/JU.0000000000001548.02","volume":"205","author":"P Sountoulides","year":"2021","unstructured":"Sountoulides P, Pyrgidis N, Brookman-May S, Mykoniatis I, Karasavvidis T, Hatzichristou D (2021) Reply by Authors. J Urol 205:966. https:\/\/doi.org\/10.1097\/JU.0000000000001548.02","journal-title":"J Urol"},{"key":"6839_CR20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/01.ju.0000048980.33855.90","volume":"169","author":"Hb Joshi","year":"2003","unstructured":"Joshi Hb, Stainthorpe A, MacDONAGH RP, Keeley Fx (2003) Timoney A.g. Indwelling Ureteral Stents: Evaluation of Symptoms, Quality of Life and Utility. J Urol 169:1065\u20131069. https:\/\/doi.org\/10.1097\/01.ju.0000048980.33855.90","journal-title":"J Urol"},{"key":"6839_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1442-2042.2006.01385.x","volume":"13","author":"EC-L Chou","year":"2006","unstructured":"Chou EC-L, Lin AT, Chen K-K, Chang LS (2006) Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors. Int J Urol Off J Jpn Urol Assoc 13:682\u2013685. https:\/\/doi.org\/10.1111\/j.1442-2042.2006.01385.x","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"key":"6839_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12885-020-6620-2","volume":"20","author":"MC Hupe","year":"2020","unstructured":"Hupe MC, Dormayer L, Ozimek T, Struck JP, Hennig MJP, Klee M et al (2020) Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer. BMC Cancer 20:140. https:\/\/doi.org\/10.1186\/s12885-020-6620-2","journal-title":"BMC Cancer"},{"key":"6839_CR23","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.juro.2017.06.020","volume":"198","author":"B Kiss","year":"2017","unstructured":"Kiss B, Furrer MA, Wuethrich PY, Burkhard FC, Thalmann GN, Roth B (2017) Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence. J Urol 198:1263\u20131268. https:\/\/doi.org\/10.1016\/j.juro.2017.06.020","journal-title":"J Urol"},{"key":"6839_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2020.07.034","author":"TS Miest","year":"2020","unstructured":"Miest TS, Sharma V, Boeri L, Tollefson MK, Thompson RH, Boorjian SA et al (2020) Does ureteral stent drainage prior to cystectomy increase the risk of subsequent upper tract urothelial carcinoma and ureteral complications? Urology. https:\/\/doi.org\/10.1016\/j.urology.2020.07.034","journal-title":"Urology"},{"key":"6839_CR25","doi-asserted-by":"publisher","first-page":"102241","DOI":"10.1016\/j.clgc.2024.102241","volume":"22","author":"P Scilipoti","year":"2024","unstructured":"Scilipoti P, Moschini M, de Angelis M, Longoni M, Afferi L, Lonati C et al (2024) Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer. Clin Genitourin Cancer 22:102241. https:\/\/doi.org\/10.1016\/j.clgc.2024.102241","journal-title":"Clin Genitourin Cancer"},{"key":"6839_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000535024","volume":"108","author":"Y Volz","year":"2024","unstructured":"Volz Y, Trappmann R, Ebner B, Eismann L, Enzinger B, Hermans J et al (2024) Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk? Urol Int 108:42\u201348. https:\/\/doi.org\/10.1159\/000535024","journal-title":"Urol Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06839-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06839-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06839-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:53:15Z","timestamp":1791193995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06839-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6839"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06839-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None declared.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee of the LMU University Hospital (approval number: 23\u20130586). All procedures were conducted in accordance with the Declaration of Helsinki and applicable institutional and national ethical standards.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"725"}}